Traumatic Brain Injury
Research activity is centred on severe traumatic brain injury, with a focus on acute neurological injury and recovery after major brain trauma.
- Neurotrauma
- Severe traumatic brain injury
- Acute brain injury
The sponsor’s clinical interest in this area includes neurological damage assessment and treatment strategies aimed at improving outcomes after central nervous system injury.
Stem Cell Therapy
The trial portfolio includes investigation of mesenchymal stem cells as a therapeutic option in neurological repair and tissue response following traumatic brain injury.
- Mesenchymal stem cells
- Cell-based therapy
- Regenerative medicine
This reflects an interest in regenerative approaches for conditions where conventional neuroprotective strategies remain limited.
Biomarkers of Brain Damage
Clinical research also targets biomarkers associated with axonal injury and early detection of brain damage after trauma.
- Neurofilament light chain
- Plasmatic biomarkers
- Brain injury monitoring
These interests support evaluation of biological signals linked to neurological deterioration and post-injury response.
Hospital-Based Multicenter Neurology Research
As a scientific coordinator in a hospital-based setting, the sponsor is involved in collaborative clinical research across multiple sites in Italy, with emphasis on coordinated care for neurosurgical and neurological patients.
- Multicenter clinical research
- Acute neurological care
- Clinical coordination
The research environment is closely tied to inpatient management of critical neurological conditions.
